Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ebbing

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Seizure|December 1, 1994
Case summary: KateF J Kirkham, A Ebbing
Journal of Pediatric Gastroenterology and Nutrition|November 5, 1997
Celiac disease: an uncommon cause of recurrent intussusceptionR Germann, M Kuch, K Prinz, et al.
Poultry Science|May 17, 2018
Copper requirements of broiler breeder hensE Berwanger, S L Vieira, C R Angel, et al.
Nanotechnology|June 10, 2011
Template-assisted self-assembly of individual and clusters of magnetic nanoparticlesG A Badini Confalonieri, V Vega, A Ebbing, et al.
Oncotarget|February 11, 2016
ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3Eva A Ebbing, Jan Paul Medema, Helene Damhofer, et al.
Gastroenterology|March 14, 2017
Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal TransitionEva A Ebbing, Anne Steins, Evelyn Fessler, et al.
Drug Delivery|November 28, 2017
Systemic effects of angiogenesis inhibition alter pharmacokinetics and intratumoral delivery of nab-paclitaxelAnne Steins, Eva A Ebbing, Marcel C M Pistorius, et al.
Scientific Reports|September 7, 2018
A systematic review and meta-analysis of prognostic biomarkers in resectable esophageal adenocarcinomasAafke Creemers, Eva A Ebbing, Thomas C Pelgrim, et al.
Oncotarget|June 22, 2018
The dynamics of HER2 status in esophageal adenocarcinomaAafke Creemers, Eva A Ebbing, Gerrit K J Hooijer, et al.
International Journal of Cancer|April 25, 2019
Chemoradiation induces epithelial-to-mesenchymal transition in esophageal adenocarcinomaAnne Steins, Eva A Ebbing, Aafke Creemers, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Seizure|December 1, 1994
Case summary: KateF J Kirkham, A Ebbing
Journal of Pediatric Gastroenterology and Nutrition|November 5, 1997
Celiac disease: an uncommon cause of recurrent intussusceptionR Germann, M Kuch, K Prinz, et al.
Poultry Science|May 17, 2018
Copper requirements of broiler breeder hensE Berwanger, S L Vieira, C R Angel, et al.
Nanotechnology|June 10, 2011
Template-assisted self-assembly of individual and clusters of magnetic nanoparticlesG A Badini Confalonieri, V Vega, A Ebbing, et al.
Oncotarget|February 11, 2016
ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3Eva A Ebbing, Jan Paul Medema, Helene Damhofer, et al.
Gastroenterology|March 14, 2017
Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal TransitionEva A Ebbing, Anne Steins, Evelyn Fessler, et al.
Drug Delivery|November 28, 2017
Systemic effects of angiogenesis inhibition alter pharmacokinetics and intratumoral delivery of nab-paclitaxelAnne Steins, Eva A Ebbing, Marcel C M Pistorius, et al.
Scientific Reports|September 7, 2018
A systematic review and meta-analysis of prognostic biomarkers in resectable esophageal adenocarcinomasAafke Creemers, Eva A Ebbing, Thomas C Pelgrim, et al.
Oncotarget|June 22, 2018
The dynamics of HER2 status in esophageal adenocarcinomaAafke Creemers, Eva A Ebbing, Gerrit K J Hooijer, et al.
International Journal of Cancer|April 25, 2019
Chemoradiation induces epithelial-to-mesenchymal transition in esophageal adenocarcinomaAnne Steins, Eva A Ebbing, Aafke Creemers, et al.
Pageof 2